Anti-CCL2 Polyclonal Antibody
應(yīng)用 IHC
稀釋比例IHC 1:50-200.
交叉反應(yīng)Human

產(chǎn)品型號(hào)：K106631P

更新時(shí)間：2022-08-15

廠商性質(zhì)：生產(chǎn)廠家

訪問量：944

服務(wù)熱線

010-50973130

立即咨詢

產(chǎn)品分類

PRODUCT CLASSIFICATION

產(chǎn)品介紹

Anti-CCL2 Polyclonal Antibody

英文名稱	Anti-CCL2 Polyclonal Antibody
宿主	Rabbit
別名	MCP1;SCYA2;MCP-1;HC11
應(yīng)用	IHC
稀釋比例	IHC 1:50-200.
交叉反應(yīng)	Human
蛋白分子量	11kDa
Gene ID	6347
保存	Store at -20°C. Avoid freeze / thaw cycles.
儲(chǔ)存液	Buffer: PBS with 0.03% Proclin300, 50% glycerol, pH7.3.
純化方法	Affinity purification
亞型	IgG
免疫原	A synthetic peptide of human CCL2
性狀	液體
Public Immunogen Range	A synthetic peptide of human CCL2
Subcellular Locations	Cytoplasm
Swiss Prot	P13500
克隆類型	Polyclonal Antibody
背景資料	Chemotactic factor that attracts monocytes and basophils but not neutrophils or eosinophils. Augments monocyte anti-tumor activity. Has been implicated in the pathogenesis of diseases characterized by monocytic infiltrates, like psoriasis, rheumatoid arthritis or atherosclerosis. May be involved in the recruitment of monocytes into the arterial wall during the disease process of atherosclerosis.